Abstract:Radiotherapy (RT), the major anti-cancer modality for more than half of cancer patients after diagnosis, has the advantage of local tumor control with relatively less systematic side effects comparing to chemotherapy. However, the efficacy of RT is limited by acquired tumor resistance leading to the risks of relapse and metastasis. To further enhance the efficacy of RT, with the renaissances of targeted immunotherapy (TIT), increasing interests are raised on RT combined with TIT including cancer vaccines, T-cell therapy, and antibody-based immune checkpoint blockers (ICB) such as anti-CTLA-4 and anti-PD1/PD-L1. In achieving a significant synergy between RT and TIT, the dynamics of radiation-induced response in tumor cells and stromal cells, especially the cross-talk between tumor cells and immune cells in the irradiated tumor microenvironment (ITME) as highlighted in recent literature are to be elucidated. The abscopal effect refereeing the RT-induced priming function outside of ITME could be compromised by the immune-suppressive factors such as CD47 and PD-L1 on tumor cells and Treg induced or enhanced in the ITME. Cell surface receptors temporally or permanently induced and bioactive elements released from dead cells could serve antigenic source (radiation-associated antigenic proteins, RAAPs) to the host and have functions in immune regulation on the tumor. This review is attempted to summarize a cluster of factors that are inducible by radiation and targetable by antibodies, or have potential to be immune regulators to synergize tumor control with RT. Further characterization of immune regulators in ITME will deepen our understanding of the interplay among immune regulators in ITME and discover new effective targets for the combined modality with RT and TIT.

Reactive oxygen species in immune cells: A new antitumor target

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Reactive oxygen species-powered cancer immunotherapy: Current status and challenges

Role of antioxidants in modulating anti-tumor T cell immune resposne

Thioredoxin Activity Confers Resistance Against Oxidative Stress In Tumor-Infiltrating Nk Cells

Research Progress on Mitochondria Regulating Tumor Immunity.

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy

Function of reactive oxygen species in myeloid-derived suppressor cells

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Immune targets in the tumor microenvironment treated by radiotherapy

Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death

Roles of Reactive Oxygen Species in Inflammation and Cancer

The role of reactive oxygen species in tumor treatment

Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy

Controlling Cancer Cells Using Reactive Oxygen Species

Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment

The Role of Redox Environment in Tumors

Reactive Oxygen Species and Antioxidants in Carcinogenesis and Tumor Therapy